Kagoshima Shi, Japan

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)

ONO-4059 Study in Patients With Steroid-resistant Pemphigus

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.

A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

A Study to Assess the Effect of Dexpramipexole in Participants With Severe Eosinophilic Asthma.

This is a multicenter, randomized, double-blind, placebo controlled, parallel group study designed to evaluate the efficacy and safety of dexpramipexole in participants with severe, inadequately controlled asthma with eosinophilic phenotype on medium to high-dose inhaled corticosteroids (ICS )and at least one additional asthma controller medication with or without oral corticosteroids (OCS). Approximately 1400 participants will be randomized globally. Participants will receive dexpramipexole, or placebo, administered orally, over a 52-week treatment period. The study also includes a post-treatment follow-up period of 4 weeks.

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants with Moderate to Severe Active Crohn's Disease (CD) in Japan

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

The study includes a 3-month, randomized, double-blind treatment period in which participants receive either galcanezumab or placebo, followed by a 9-month open-label extension in which all participants receive galcanezumab. Enrollment in the European Union may also include participants 6 to 11 years of age.

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine